Finding your individual microdose

TL;DR

• Always start with the smallest measurable dose.
• Inhalation: fast (5-10 min), well controllable, short duration.
• Oral: slow (30-120 min), harder to control, long duration — patience before redosing!
• A dosing diary (time, amount, effect) speeds up finding the optimal dose.

Protocol for inhalation (vaporiser)

Start with a single short puff of a low-potency product (< 15% THC), wait 10-15 minutes and assess the effect. Only then take another puff if needed. Due to the rapid onset (5-10 min), inhalation is the best-controllable method for microdosing, albeit with the known respiratory downsides of smoking/vaping.

Protocol for oral intake (oil, capsule)

Start with 1-2.5 mg THC and wait at least 2 hours before taking another dose — the delayed onset (30-120 min, depending on stomach contents and liver metabolism) otherwise tempts premature redosing, leading to unintentionally high total doses. Only increase after several days of stable experience with the current dose.

Swiss legal framework and procurement channels in titration

In Switzerland, controlled titration is strongly shaped by the legal framework of the chosen product. Since August 2022, doctors can prescribe medical cannabis directly without having to obtain an exceptional permit from the Federal Office of Public Health (BAG). These medical preparations have precisely declared active ingredient contents, enabling precise titration in the milligram range. For consumers outside the medical system, the cantonal pilot trials under Article 8b of the Narcotics Act (BetmG) offer a legal option to purchase standardized products for controlled dose-finding.

Those who instead rely on freely available CBD products must respect the Swiss limit of less than one percent total THC. Products below this threshold are not considered narcotics under the Narcotics Act. Titration is also relevant for these CBD preparations, as cannabidiol also exhibits an individual dose-response curve. Titration is more difficult with illegally acquired cannabis from the black market, as the exact active ingredient content of THC and CBD is unknown. This significantly increases the risk of dosing errors and undesirable effects in everyday life.

• Since August 2022, medical cannabis has been directly prescribable by doctors without an exceptional permit from the BAG.
• Pilot trials in Swiss cities enable the legal purchase of standardized products with a known THC content.
• Freely available CBD products in Switzerland must not exceed a total THC level of under one percent.
• Black market products complicate precise titration due to fluctuating and unclear active ingredient concentrations.

The importance of the biphasic effect in dose finding

A central phenomenon in the titration of cannabinoids is the so-called biphasic effect. This states that low and high doses of the same active ingredient can produce completely opposite effects in the human body. While a minimal dose in the context of microdosing is often perceived as stimulating, focus-enhancing, or mildly relaxing, a significantly higher dose can have the opposite effect. Too much THC, for example, can trigger fatigue, lethargy, or even inner restlessness and discomfort, instead of promoting the desired balance.

In practice, this means for titration that more does not automatically result in a stronger positive effect. As soon as the optimal therapeutic or functional range is exceeded, the benefits often decrease while side effects increase. The goal of the gradual increase is therefore to find the individual peak of this curve. Consumers should only increase the dose as long as the desired effects improve, and immediately stop increasing or reduce the dose as soon as the first signs of an overdose or undesirable side effects become noticeable.

• The biphasic effect describes opposite effects of cannabinoids at low versus high dosages.
• Low doses often have a stimulating or gently balancing effect, while excessively high doses can be sedating or unpleasant.
• The optimal dose lies at the peak, where the benefits are maximized and side effects are minimized.
• Beyond a certain point, a continuous dose increase does not lead to better, but to worse results.

Factors influencing individual tolerance and active ingredient absorption

Finding the right dose is a highly individual process, as the response to cannabinoids is influenced by numerous biological factors. The body's own endocannabinoid system is uniquely configured in every individual in terms of receptor density and sensitivity. In addition, genetic predispositions play a crucial role in the breakdown of active substances in the liver. Specific enzymes are responsible for the metabolism of THC and CBD; if this enzyme system works faster or slower due to genetics, the timeframe and intensity of the effect shift noticeably.

In addition to genetics, body weight, body fat percentage, and overall metabolism also influence the absorption of active substances. Since cannabinoids are lipophilic, meaning fat-soluble, they accumulate in adipose tissue and are released from there with a delay. Current diet, particularly the consumption of high-fat foods prior to oral ingestion, can also massively increase bioavailability. Finally, regular intake alters the body's tolerance threshold, which is why a dose once established must be re-evaluated after prolonged use or after a break in consumption.

• Individual receptor density in the endocannabinoid system determines the baseline sensitivity to cannabinoids.
• Genetic differences in liver metabolism influence how quickly active substances are broken down and excreted.
• Since cannabinoid molecules are fat-soluble, body composition and fatty foods play a major role in absorption.
• Regular consumption leads to the development of tolerance, which shifts the dose-response relationship over time.

Risiks of driving incapacity and legal consequences in Switzerland

When titrating THC-containing products in Switzerland, the strict road traffic legislation must be strictly observed. A strict zero-tolerance policy applies to active drivers. The legal limit for the detection of THC in blood is a mere 1.5 micrograms per litre of blood. Since this limit is set extremely low, practically any detectable consumption of THC cannabis leads to driving incapacity in the legal sense. Even after the noticeable effects have subsided, the blood limit can still be exceeded for many hours or even days.

Increasing the dose during titration also extends the window of time in which the blood limit remains exceeded. A driving licence revocation, heavy fines, and, in the worst case, criminal consequences are the result of a positive traffic check. Caution is also advised when using CBD products with less than one percent THC, as regular or high-dose consumption of these products can also cause the THC limit in the blood to be exceeded. Careful planning of consumption times and driving breaks is therefore essential.

• In Switzerland, a zero-tolerance policy applies to road traffic, with a THC limit of 1.5 micrograms per litre of blood.
• Legal driving incapacity often persists even when the subjectively noticeable effect has already completely subsided.
• Higher doses during titration extend the elimination time and thus the risk of a positive test result in road traffic.
• Even the regular consumption of CBD products with less than one percent THC can lead to the limit being exceeded.

FAQ